These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 1785943)

  • 1. The level of urinary epidermal growth factor is not influenced by the extent of psoriatic lesions.
    Kondo S; Sato N; Aso K
    Arch Dermatol Res; 1991; 283(8):516-8. PubMed ID: 1785943
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Depressed urinary excretion of epidermal growth factor in psoriasis.
    Madeddu P; Ena P; Parpaglia PP; Patteri G; Bacciu S; Maioli M; Glorioso N
    Am J Nephrol; 1991; 11(4):313-7. PubMed ID: 1799191
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decreased urinary epidermal growth factor in children with acute renal failure: epidermal growth factor/creatinine ratio not a reliable parameter for urinary epidermal growth factor excretion.
    Tsau YK; Sheu JN; Chen CH; Teng RJ; Chen HC
    Pediatr Res; 1996 Jan; 39(1):20-24. PubMed ID: 8825381
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aging and urinary excretion of epidermal growth factor.
    Chou JS; Reiser IW; Porush JG
    Ann Clin Lab Sci; 1997; 27(2):116-22. PubMed ID: 9098510
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of heparin-binding EGF-like growth factor and amphiregulin in the epidermal proliferation of psoriasis in cooperation with TNFalpha.
    Yoshida A; Kanno H; Watabe D; Akasaka T; Sawai T
    Arch Dermatol Res; 2008 Jan; 300(1):37-45. PubMed ID: 17960400
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alteration and significance of heparin-binding epidermal-growth-factor-like growth factor in psoriatic epidermis.
    Zheng Y; Peng Z; Wang Y; Tan S; Xi Y; Wang G
    Dermatology; 2003; 207(1):22-7. PubMed ID: 12835543
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of psoriasis activity and topical treatment on plasma epidermal growth factor (EGF) and its soluble receptor (sEGFR).
    Szterling-Jaworowska M; Baran A; Myśliwiec H; Flisiak I
    J Dermatolog Treat; 2018 Mar; 29(2):135-139. PubMed ID: 28621164
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of a receptor binding assay with a radioimmunoassay for measuring human epidermal growth factor-urogastrone in urine.
    Nexø E; Lamberg SI; Hollenberg MD
    Scand J Clin Lab Invest; 1981 Oct; 41(6):577-82. PubMed ID: 6977820
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of psoriasis activity on epidermal growth factor (EGF) and the concentration of soluble EGF receptor in serum and plaque scales.
    Flisiak I; Szterling-Jaworowska M; Baran A; Rogalska-Taranta M
    Clin Exp Dermatol; 2014 Jun; 39(4):461-7. PubMed ID: 24825137
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Urinary epidermal growth factor and serum pepsinogen I in patients with duodenal ulcers].
    Kolster J; de Kolster CC; Carvajal A; Castro J; González E; Brasel JA; Callegari C
    G E N; 1993; 47(1):16-21. PubMed ID: 8243967
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urinary epidermal growth factor excretion in children with chronic renal failure.
    Tsau Y; Chen C
    Am J Nephrol; 1999; 19(3):400-4. PubMed ID: 10393378
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urinary levels of epidermal growth factor, interleukin-6 and monocyte chemoattractant protein-1 may act as predictor markers of renal function outcome in immunoglobulin A nephropathy.
    Stangou M; Alexopoulos E; Papagianni A; Pantzaki A; Bantis C; Dovas S; Economidou D; Leontsini M; Memmos D
    Nephrology (Carlton); 2009 Sep; 14(6):613-20. PubMed ID: 19143943
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recovery of epidermal growth factor in voided urine of patients with bladder cancer.
    Messing EM; Murphy-Brooks N
    Urology; 1994 Oct; 44(4):502-6. PubMed ID: 7941190
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiproliferative factor, heparin-binding epidermal growth factor-like growth factor, and epidermal growth factor in men with interstitial cystitis versus chronic pelvic pain syndrome.
    Keay S; Zhang CO; Chai T; Warren J; Koch K; Grkovic D; Colville H; Alexander R
    Urology; 2004 Jan; 63(1):22-6. PubMed ID: 14751340
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical study of epidermal growth factor in the urine of the patients with urological malignant tumor].
    Fuse H; Mizuno I; Kazama T; Katayama T; Kurimoto F
    Nihon Hinyokika Gakkai Zasshi; 1991 Apr; 82(4):600-6. PubMed ID: 2051697
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic cystitis: excretion of epidermal growth factor (EGF)/urogastrone (URO).
    Holm-Bentzen M; Lose G; Sørensen K; Jørgensen L; Nexø E
    Urol Res; 1987; 15(4):203-5. PubMed ID: 3499698
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidermal growth factor in urine of nonpregnant women and pregnant women throughout pregnancy and at delivery.
    Hofmann GE; Rao CV; Brown MJ; Murray LF; Schultz GS; Siddiqi TA
    J Clin Endocrinol Metab; 1988 Jan; 66(1):119-23. PubMed ID: 3257216
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human psoriatic skin in organ culture: comparison with normal skin exposed to exogenous growth factors and effects of an antibody to the EGF receptor.
    Varani J; Kang S; Stoll S; Elder JT
    Pathobiology; 1998; 66(6):253-9. PubMed ID: 9769471
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Altered [125I]epidermal growth factor binding and receptor distribution in psoriasis.
    Nanney LB; Stoscheck CM; Magid M; King LE
    J Invest Dermatol; 1986 Mar; 86(3):260-5. PubMed ID: 3018088
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urinary epidermal growth factor (EGF) levels and epidermal growth factor receptor (EGF-R) expression in human cerebral tumors. Clinical considerations.
    Bello L
    J Neurosurg Sci; 1996; 40(3-4):167-82. PubMed ID: 9165424
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.